We are live on ! Find out more
CM

Crystalline Management Portfolio holdings

AUM $112M
1-Year Est. Return 21.13%
This Fund
S&P 500
This Quarter Est. Return
+12.49%
1 Year Est. Return
+21.13%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$139M
AUM Growth
-$2.04M
Cap. Flow
-$2.3M
Cap. Flow %
-1.65%
Top 10 Hldgs %
42.48%
Holding
162
New
34
Increased
8
Reduced
6
Closed
39

Sector Composition

Rank Sector Weight
1 Financials 24.76%
2 Technology 13.06%
3 Energy 8%
4 Healthcare 6.16%
5 Industrials 5.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IFIN.WS
101
DELISTED
InFinT Acquisition Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per whole share
IFIN.WS
$1.88K ﹤0.01%
50,000
JAQCW
102
DELISTED
Jupiter Acquisition Corporation Warrants
JAQCW
$1.75K ﹤0.01%
50,000
ADEX.WS
103
DELISTED
Adit EdTech Acquisition Corp Warrants
ADEX.WS
$1.7K ﹤0.01%
24,300
OHAAW
104
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
$1.39K ﹤0.01%
50,000
ASCBW
105
DELISTED
A SPAC II Acquisition Corp. Warrant
ASCBW
$1.38K ﹤0.01%
50,000
NCACW
106
DELISTED
Newcourt Acquisition Corp Warrant
NCACW
$1.19K ﹤0.01%
50,000
MLECW icon
107
Moolec Science SA Warrant
MLECW
$187K
$1.17K ﹤0.01%
25,000
ANGHW icon
108
Anghami Inc Warrants
ANGHW
$1.07K ﹤0.01%
36,400
JWSM.WS
109
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$959 ﹤0.01%
23,983
HCMAW
110
DELISTED
HCM Acquisition Corp Warrant
HCMAW
$860 ﹤0.01%
50,000
CCTSW
111
DELISTED
Cactus Acquisition Corp. 1 Limited Warrant
CCTSW
$853 ﹤0.01%
20,000
BMAC.WS
112
DELISTED
Black Mountain Acquisition Corp. Warrants, exercisable for one share of Class A Common Stock
BMAC.WS
$811 ﹤0.01%
17,250
RBT.WS
113
DELISTED
Rubicon Technologies, Inc. Warrants, each warrant is exercisable for 1/8th of a share of Class A Common Stock at an exercise price of $92.00r share
RBT.WS
$800 ﹤0.01%
50,000
CXAC.WS
114
DELISTED
C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
CXAC.WS
$742 ﹤0.01%
20,000
FAASW
115
DELISTED
DigiAsia Corp Warrant
FAASW
$620 ﹤0.01%
23,840
PUCKW
116
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
$554 ﹤0.01%
20,000
MACAW
117
DELISTED
Moringa Acquisition Corp Warrant
MACAW
$415 ﹤0.01%
12,500
NOGNW
118
DELISTED
Nogin, Inc. Warrant
NOGNW
$410 ﹤0.01%
20,600
AGILW
119
DELISTED
AgileThought Inc Warrant
AGILW
$139 ﹤0.01%
14,000
LFACW
120
DELISTED
LF Capital Acquisition Corp. II Warrants
LFACW
$46 ﹤0.01%
12,500
AMBI.WS
121
DELISTED
Ambipar Emergency Response Warrants
AMBI.WS
-10,000
Closed -$5K
CDT icon
122
CDT Equity Inc
CDT
$1.81M
0
-$2.47M
FHN icon
123
First Horizon
FHN
$12.2B
-90,000
Closed -$1.01M
PBR.A icon
124
Petrobras Class A
PBR.A
$109B
-279,300
Closed -$3.45M
PSQH icon
125
PSQ Holdings
PSQH
$14.8M
-17,404
Closed -$2.68M

Similar funds

Crystalline Management's Q3 2023 Portfolio in Review

As of Q3 2023, Crystalline Management held 162 positions worth $139M, down 1.4% from $141M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Crystalline Management's Q3 2023 filing shows 34 new, 8 increased, 6 reduced and 39 closed positions. Its largest new stake was Denbury Inc.: 100,393 shares worth $9.84M. The largest sale was Univar Solutions Inc., an estimated $8.08M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 25% a quarter earlier, followed by Technology and Energy.

  • Crystalline Management's largest Q3 2023 buy was Denbury Inc.: 100,393 shares worth $9.84M.
  • Crystalline Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2023, an estimated $1.6M increase.
  • Crystalline Management's biggest Q3 2023 reduction was Artemis Strategic Investment Corporation Class A Common Stock, cutting an estimated $2.92M.
  • Crystalline Management fully exited Univar Solutions Inc. in Q3 2023, selling an estimated $8.08M.
  • Crystalline Management's ten largest holdings make up 42% of its $139M portfolio in Q3 2023.
  • Crystalline Management opened 34 new positions and closed 39 in Q3 2023.
  • Crystalline Management's portfolio value fell 1.4% quarter-over-quarter to $139M.

Based on Crystalline Management's 13F filing for Q3 2023, filed 13 Nov 2023.